Sensus Healthcare, INC 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NASDAQ
Sensus Healthcare's Q2 2026 results show a significant 68.5% revenue decline and a widened net loss, impacted by reduced unit sales and a shift towards revenue recognition over time.
NASDAQ
Sensus Healthcare reports a significant revenue decrease in Q1 2026 due to fewer unit sales and a shift towards service-based revenue models, impacting gross margins.
NASDAQ
Sensus Healthcare reported a significant net loss in Q3 2025, driven by a 22% revenue decrease and substantial increases in operating expenses, despite an improved cash position.
NASDAQ
Sensus Healthcare, Inc. reported a significant net loss and revenue decline for the second quarter and first half of 2025, primarily due to lower unit sales to a major customer and increased operating expenses.
NASDAQ
Sensus Healthcare's Q1 2025 results reveal a decrease in revenue and a net loss, driven by lower sales and increased operating expenses.
NASDAQ
Sensus Healthcare's Q3 2024 results show a significant increase in revenue driven by higher unit sales to a major customer, alongside improvements in gross profit.
NASDAQ
Sensus Healthcare's Q2 2024 results show a significant increase in revenue, driven by higher unit sales, but also reveal a material weakness in internal controls.
NASDAQ
Sensus Healthcare's first quarter of 2024 saw a significant increase in revenue and a return to profitability, driven by higher unit sales.